Clinical Trials Directory

Trials / Unknown

UnknownNCT06052540

Probiotic Supplementation in Children Affected by Upper Respiratory Infections

Effetto Della Supplementazione di Una Miscela di Ceppi Probiotici (Bifidobacterium Breve M-16V, Bifidobacterium Lactis HN019, Lactobacillus Rhamnosus HN001) in Bambini Febbrili Con Infezioni Delle Alte Vie Respiratorie

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Academic / Other
Sex
All
Age
29 Days – 4 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized non-pharmacological Intervention study is to evaluate the effects of probiotic supplements (Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnosus HN001) on children affected by upper respiratory tract infections. The main questions it aims to answer are: * probiotic formulation can reduce intensity and duration of fever in children affected by upper respiratory tract infections * probiotic formulation can influence the gut microbiota composition in children affected by upper respiratory tract infections Participants will be asked to take probiotic supplements or placebo for 14 days and to collect three fecal samples: before probiotic supplementation (T0), 14 days after probiotic supplementation (T1), and 12 months after the enrollment (T2).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic supplement* Stick: Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnosus HN001 + Maltodestrins * Drops: Bifidobacterium breve M-16V, Bifidobacterium lactis HN019, Lactobacillus rhamnosus HN001 + Medium chain triglycerides, vegetable fats, emulsifier, and maltodextrin.
DIETARY_SUPPLEMENTPlacebo* Drops: Medium Chain Triglycerides, vegetal oil, E471, and maltodextrin * Stick: Maltodextrin.

Timeline

Start date
2021-09-01
Primary completion
2023-06-30
Completion
2024-06-30
First posted
2023-09-25
Last updated
2023-09-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06052540. Inclusion in this directory is not an endorsement.